OCRA News
OCRA-Funded Research Identifies New “Master” Drug Targets for Ovarian Cancer
An interdisciplinary group of researchers from around the country analyzed tumor samples from nearly 10,000 patients with 34 types of cancer to reveal unique genetic switches associated with each tumor type…
Apply Today for OCRA’s 2022 Advocate Leader Program
The application period has now closed. Apply today to join survivors, caregivers and activists across the country to affect change for those impacted by ovarian cancer…
Liya Ding, PhD | Meet a Scientist
Dr. Liya Ding, of Dana-Farber Cancer Institute, is a 2021 recipient of OCRA’s Liz Tilberis Early Career Award. With her project, “Targeting Therapeutic Resistance to PARP Inhibition in Ovarian Cancer,” Dr…
How to Cope With Cancer
A cancer diagnosis of any type can stress both body and mind, but ovarian cancer takes a particularly high psychological toll on those living with the disease, according to recent research…
FDA Approves Drug to Identify Ovarian Cancer Lesions During Surgery
In what could prove to be a game-changer for ovarian cancer debulking procedures, the U.S…
Bojana Stefanovska, PhD | Meet a Scientist
Dr. Bojana Stefanovska, at University of Minnesota Twin Cities, is a 2021 recipient of OCRA’s Ann and Sol Schreiber Mentored Investigator Award…
Ascites and Ovarian Cancer
More than one-third of women with ovarian cancer develop ascites (pronounced uh٠SAI٠teez), an accumulation of fluid in the abdomen…
A Thanksgiving Message from Audra Moran, President & CEO
Dear Friends, I hope this finds you all well, staying safe, and enjoying preparations for a lovely holiday. Whether you’re gathering with loved ones or holding them in your heart as you celebrate, I wish you warmth and joy…
Working Out to Work Towards a Cure | Heroes Highlights
In this time of giving thanks, we want to take a moment to look back and express our gratitude for the OCRA Heroes who stepped up for September’s Ovarian Cancer Awareness Month to sweat it out at Ovarian Fitness events around the country, all…
The Overview: November 2021
As we head into the Thanksgiving holiday, we have much to be thankful for … an embracing and strong survivor community, supporters who remain ever committed to the cause, and brilliant grantees who are making strides every day in the search for…
Action Alert: Urge Your Elected Officials to Co-Sponsor the DIVERSE Trials Act
Clinical trials are fundamental to the discovery of new and better therapies in the fight against ovarian cancer. Yet enrollment and widespread availability remain a challenge…
Going to Great Lengths to Support the Cause and Strengthen a Marriage | Survivor Stories
Shelley O’Keefe had been experiencing weird bruising, some fatigue, and lower back pain for a few years…